NERI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 254
AS - Asia 130
EU - Europa 95
SA - Sud America 22
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 503
Nazione #
US - Stati Uniti d'America 249
SG - Singapore 101
IT - Italia 39
BR - Brasile 20
DE - Germania 20
CN - Cina 16
GB - Regno Unito 14
SE - Svezia 8
FI - Finlandia 6
CA - Canada 4
HK - Hong Kong 4
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
IN - India 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IQ - Iraq 1
MX - Messico 1
NL - Olanda 1
NO - Norvegia 1
PK - Pakistan 1
RU - Federazione Russa 1
TR - Turchia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 503
Città #
Singapore 77
Chandler 50
Hefei 15
Santa Clara 15
London 14
Munich 14
Chicago 13
Lawrence 13
Princeton 13
Dallas 12
Milan 11
Ashburn 7
Naples 6
New York 5
Stockholm 5
Turku 5
Hong Kong 4
Boston 3
Assago 2
Boardman 2
Brescia 2
Charlotte 2
Des Moines 2
Los Angeles 2
San Nicola Manfredi 2
São Paulo 2
Abaetetuba 1
Altamira 1
Andover 1
Ankara 1
Augusta 1
Bagé 1
Barueri 1
Basti 1
Brooklyn 1
Byram 1
Campinas 1
Council Bluffs 1
Da Nang 1
Denver 1
Dhaka 1
Duhok 1
Greenville 1
Hanover 1
Helsinki 1
Houston 1
Ipiaú 1
Itabira 1
Jacareí 1
Jaipur 1
Johannesburg 1
Juiz de Fora 1
King City 1
Marabá 1
Messina 1
Mexico City 1
Minsk 1
Montreal 1
Mountain View 1
Norfolk 1
Norwalk 1
Novokuznetsk 1
Olomouc 1
Palermo 1
Palhoça 1
Parma 1
Passo Fundo 1
Peshawar 1
Pianopoli 1
Porto Alegre 1
Redmond 1
Richmond 1
Rio de Janeiro 1
San Francisco 1
San Mateo 1
Santa Maria 1
Seattle 1
Serrinha 1
Settingiano 1
Sharjah 1
São Luís 1
Taboão da Serra 1
Tallahassee 1
The Dalles 1
Torino 1
West Lafayette 1
Wilmington 1
Totale 359
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 87
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 44
In Vitro Silencing of lncRNAs Using LNA GapmeRs 42
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 41
Znf521 enhances mll‐af9‐dependent hematopoietic stem cell transformation in acute myeloid leukemias by altering the gene expression landscape† 39
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells 38
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network 38
The non-coding RNA landscape of plasma cell dyscrasias 32
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 28
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 26
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 22
The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma 22
Dissecting the biological relevance and clinical impact of lncrna miat in multiple myeloma 21
Epigenetic regulation of mitochondrial quality control genes in multiple myeloma: A sequenom massarray pilot investigation on hmcls 21
Genomic instability in multiple myeloma: A “non‐coding rna” perspective 18
Totale 519
Categoria #
all - tutte 6.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 1 0 0 0 2 0 0
2021/202237 0 0 0 4 0 0 10 2 7 7 7 0
2022/2023123 27 8 19 1 14 7 0 13 23 5 5 1
2023/202475 10 15 9 12 4 16 1 0 1 0 2 5
2024/2025199 24 3 7 13 12 38 8 9 7 3 29 46
2025/202680 30 46 4 0 0 0 0 0 0 0 0 0
Totale 519